AnalystsKeay Nakae
Keay Nakae's Stock Forecasts

Top 1%
#8 out of 3514 analysts
Average Return
Win Rate
55%11 out of 20
Risk vs Reward

Keay Nakae's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Ocugen IncOCGN
2020-06-03 -
Strong Buy
CareCloud IncMTBC
2017-11-14 -
Strong Buy
Arrowhead Pharmaceuticals IncARWR
2018-09-06 -
Strong Buy
Mesoblast LtdMESO
2020-12-04 -
Strong Sell
Emergent BioSolutions IncEBS
2020-05-01 -
Strong Buy

Keay Nakae's Stock Coverage

Name / Ticker# of RatingsRatingPrice TargetUpside/DownsideActionDate
Seres Therapeutics IncMCRB
1Strong Buy$16.00-55.63%Maintains
9 days ago
Femasys IncFEMY
1Strong Buy$25.00-70.80%Initiates Coverage On
19 days ago
Axcella Health IncAXLA
1Strong Buy$10.00-66.00%Maintains
2 months ago
Emergent BioSolutions IncEBS
5Strong Buy$92.00-28.37%Maintains
3 months ago
Dicerna Pharmaceuticals IncDRNA
1Strong Buy$34.00+10.32%Maintains
5 months ago
Ocugen IncOCGN
6 months ago
Arrowhead Pharmaceuticals IncARWR
2Strong Buy$97.00-28.57%Maintains
6 months ago
Mesoblast LtdMESO
1Strong Sell$7.50-6.67%Downgrades
8 months ago
9 months ago
Sonnet BioTherapeutics Holdings IncSONN
2Strong Buy$8.00-86.75%Maintains
a year ago
OncoCyte CorpOCX
a year ago
NeuBase Therapeutics IncNBSE
2Strong Buy$18.00N/AMaintains
a year ago
Arbutus Biopharma CorpABUS
1Strong Buy$5.00N/AUpgrades
a year ago
Caladrius Biosciences IncCLBS
1Strong Buy$7.00N/AMaintains
3 years ago
CareCloud IncMTBC
1Strong Buy$2.75N/AMaintains
4 years ago
Biocept IncBIOC
1Strong Buy$2.50N/AInitiates Coverage On
4 years ago
1Strong Buy$6.50N/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.